Trial Profile
Multicenter Randomized Phase II Study for the Therapy of Locally Advanced or Metastatic NSCLC (Stage IIIB/IV) With Cisplatin/Docetaxel or Oxaliplatin/Docetaxel [Multizentrische randomisierte Phase II Studie zur Therapie des lokal fortgeschrittenen oder metastasierten NSCLC (Stadium IIIB/IV) mit Cisplatin/Docetaxel oder Oxaliplatin/Docetaxel]
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Mar 2013
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Oxaliplatin (Primary) ; Cisplatin
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms Taxelox
- 28 Nov 2011 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
- 28 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Jun 2011 Results presented at the 47th Annual Meeting of the American Society of Clinical Oncology.